Effects of pantoprazole on dual antiplatelet therapy in stable angina pectoris patients after percutaneous coronary intervention.
Journal Title: Pharmacological Reports - Year 2012, Vol 64, Issue 2
Abstract
Background: Our aim was to prospectively assess the potential influence of pantoprazole therapy on the antiplatelet effects of acetylsalicylic acid (ASA) and clopidogrel (CLO) in stable angina pectoris (SAP) patients after percutaneous coronary intervention (PCI). Methods: Forty-four patients with SAP (CCS I-III) and successful PCI with stent implantation were enrolled into the study. The patients were divided into group proton pump inhibitors (PPI): 23 patients with indications for PPI (F/M = 9/14; age = 64 ± 9; standard therapy + 20 mg pantoprazole) and the control group (group C): 21 patients (F/M = 6/15; age = 64 ± 8; standard therapy). The platelet function analysis in whole blood based on impedance aggregometry (ASPI, COL, ADP, TRAP tests) using Multiplate - V2.02.11 was performed 18-24 h after the PCI + CLO loading dose (600 mg) and 30 days after PCI. Results: Both baseline patient characteristics and clinical outcomes were comparable between the study groups. There were no differences in the mean values of the platelets (PTL) tests measured at the 30(th) day after PCI between both groups (PPI vs. C: ASPI: 24.6 ± 10.0 vs. 42.1 ± 14.8U, COL: 32.9 ± 8.6 vs. 34.0 ± 7.7U, ADP: 26.8 ± 12.4 vs. 30.4 ± 8.1U, TRAP: 78.7 ± 16.6 vs. 78.1 ± 22.6U, p = ns). The mean delta values of the PTL tests (18-24 h post-PCI/30 days post-PCI) were also comparable between the groups. The PTL aggregometry results were related to time (ADP, ASPI, TRAP vs. time, p = 0.001; COL vs. time, p = 0.03) - the baseline values of ADP, ASPI, COL and TRAP tests were smaller than those measured after the one-month observation. Conclusion: Pantoprazole treatment does not impair the efficacy of dual antiplatelet therapy in patients with SAP after PCI.
Authors and Affiliations
Katarzyna Mizia-Stec, Maciej Haberka, Magdalena Mizia, Bartosz Lasota, Marcin Kunecki, Klaudia Gieszczyk, Artur Chmiel, Jacek Najda, Sławomira Kyrcz-Krzemień, Zbigniew Gąsior
Keywords
Related Articles
- EP ID EP97947
- DOI -
- Views 94
- Downloads 0
Pregabalin antinociception and its interaction with tramadol in acute model of pain.
Background: The aim of present study was to investigate the antinociceptive effect of pregabalin and tramadol either alone and or in combination on acute model of pain. Methods: The antinociceptive effect of intraperiton...
Cytisine for the treatment of nicotine addiction: from a molecule to therapeutic efficacy.
Cytisine, a natural plant alkaloid, has been marketed in Central and Eastern Europe for over 40 years for the clinical management of smoking cessation. Despite the fact that cytisine has been used by millions of smokers,...
Evaluation of terfenadine and ketoconazole-induced QT prolongation in conscious telemetered guinea pigs.
Terfenadine and ketoconazole are the most widely used positive reference agents in non-clinical cardiac repolarization safety studies. The aim of the present study was to evaluate the effects of terfenadine, ketoconazole...
Role of nitric oxide in the regulation of motor function. An overview of behavioral, biochemical and histological studies in animal models.
A compelling body of evidence suggests that nitric oxide (NO), a unique gaseous neurotransmitter and neuromodulator plays a key role in the regulation of motor function. Recently, the interest of researchers concentrates...
Glyburide for the treatment of gestational diabetes mellitus.
Insulin is the traditional treatment for gestational diabetes mellitus (GDM) unresponsive to dietary interventions. Until recently, oral hypoglycemic drugs had been contraindicated due to concerns regarding teratogenicit...